Cargando…

The Need for a Coagulation Assay after Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report

BACKGROUND: Dabigatran etexilate, a new oral anticoagulant, was recently approved as an efficacious alternative to warfarin for the prevention of first and recurrent stroke in patients with nonvalvular atrial fibrillation. Limited data are available for dabigatran use in patients with a creatinine c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Mi Ji, Jang, Hye Min, Jeong, Woo Kyo, Bang, Oh Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596111/ https://www.ncbi.nlm.nih.gov/pubmed/25749821 http://dx.doi.org/10.3988/jcn.2015.11.4.395

Ejemplares similares

Coagulation assessment with the new generation of oral anticoagulants
por: Pollack, Charles V
Publicado: (2016)

New oral anticoagulants: are coagulation units still required?
por: Altman, Raul
Publicado: (2014)

Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
por: Eun, Mi-Yeon, et al.
Publicado: (2021)

Global assays and the management of oral anticoagulation
por: Brinkman, Herm Jan M
Publicado: (2015)

Coagulation and anticoagulation in COVID-19
por: Hadid, Tarik, et al.
Publicado: (2021)

Automated calculation of coagulation activity and International Normalized Ratio in oral anticoagulant control
por: Peters, R. H. M., et al.
Publicado: (1987)

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018)

Trends in physiological coagulation factors in Japanese patients receiving novel oral anticoagulants
por: Nagao, Tomoyuki, et al.
Publicado: (2017)

Coagulation and heparin requirements during ablation in patients under oral anticoagulant drugs
por: Maury, Philippe, et al.
Publicado: (2020)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
por: Yin, Lu, et al.
Publicado: (2022)

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
por: Crooks, Michael G., et al.
Publicado: (2015)

Emergency correction of coagulation before major surgery in two elderly patients on oral anticoagulation
por: Angelo, Marzia, et al.
Publicado: (2007)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017)

Canalization effect in the coagulation cascade and the interindividual variability of oral anticoagulant response. a simulation Study
por: Corlan, Alexandru D, et al.
Publicado: (2011)

Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma
por: Serebruany, Victor
Publicado: (2016)

Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay
por: Vuimo, Tatiana S., et al.
Publicado: (2022)

Anticoagulation in Elderly Patients With Atrial Fibrillation and Renal Dysfunction
por: Cheung, Christopher C., et al.
Publicado: (2023)

Role of crotoxin in coagulation: novel insights into anticoagulant mechanisms and impairment of inflammation-induced coagulation
por: Gimenez, Bruna Terada, et al.
Publicado: (2020)

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
por: Bang, Oh Young, et al.
Publicado: (2016)

New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
por: Bang, Oh Young, et al.
Publicado: (2014)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
por: Jang, Soo Min, et al.
Publicado: (2020)

Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists
por: Sakai, Takahiro, et al.
Publicado: (2022)

Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries
por: Baik, Seo Hyon, et al.
Publicado: (2016)

Comparison of laboratory and immediate diagnosis of coagulation for patients under oral anticoagulation therapy before dental surgery
por: Kruse-Loesler, Birgit, et al.
Publicado: (2005)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021)

Coagulation Proteins Influencing Global Coagulation Assays in Cirrhosis: Hypercoagulability in Cirrhosis Assessed by Thrombomodulin-Induced Thrombin Generation Assay
por: Youngwon, Nam, et al.
Publicado: (2013)

Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
por: Bang, Oh Young, et al.
Publicado: (2023)

Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation
por: Jang, Gyeong-Won, et al.
Publicado: (2021)

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
por: Mueck, Wolfgang, et al.
Publicado: (2013)

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
por: Bowles, Louise, et al.
Publicado: (2020)

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants
por: Lee, Ji Yun, et al.
Publicado: (2021)

Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants
por: Wada, Ryo, et al.
Publicado: (2021)

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
por: Wilks, Mailey L.
Publicado: (2022)

Dysfunction in the coagulation system and schizophrenia
por: Hoirisch-Clapauch, S, et al.
Publicado: (2016)

Advances in Oral Coagulants
por: Pollak, Eleanor S.
Publicado: (2013)

A novel oral anticoagulant, dabigatran, in acute renal infarction
por: Altın, Cihan, et al.
Publicado: (2015)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
por: Han, Seongwook, et al.
Publicado: (2021)

To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
por: Ahuja, Tania, et al.
Publicado: (2023)

Hemodialysis without Anticoagulation for a Patient with Chronic Disseminated Intravascular Coagulation
por: Yamanouchi, Masayuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pmo7hos3h20i12kj76875sfpnu